{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/clinical-trial-registration-and-updates-anzctr”
},
“@id”: “https://www.clinicalstudies.in/clinical-trial-registration-and-updates-anzctr”,
“headline”: “SOP for Clinical Trial Registration and Updates in ANZCTR”,
“name”: “SOP for Clinical Trial Registration and Updates in ANZCTR”,
“description”: “Comprehensive SOP outlining sponsor and investigator responsibilities for registering clinical trials in ANZCTR, maintaining updates, and ensuring compliance with HDEC, Medsafe, WHO, and ICMJE requirements.”,
“keywords”: “Trial registration SOP New Zealand, SOP for ANZCTR registration NZ, SOP for clinical trial registry submissions NZ, SOP for Medsafe registry compliance, SOP for HDEC registry submissions, SOP for investigator responsibilities trial registration NZ, SOP for sponsor obligations NZ registry, SOP for CRO registry support NZ, SOP for registry update timelines NZ, SOP for protocol registration NZ, SOP for results posting NZ, SOP for transparency compliance NZ, SOP for registry audits NZ, SOP for inspection readiness registry NZ, SOP for trial subject protection NZ registry, SOP for WHO registry requirements NZ, SOP for ICMJE compliance trial registration NZ, SOP for ethics approval and registry NZ, SOP for registry data accuracy NZ, SOP for record maintenance registry NZ, SOP for regulatory compliance registry NZ, SOP for GCP compliance registry NZ, SOP for trial disclosure NZ, SOP for registry reporting NZ, SOP for accountability in trial registration NZ”,
“articleSection”: “Standard Operating Procedure”,
“datePublished”: “2025-08-28”,
“dateModified”: “2025-08-28”,
“author”: { “@type”: “Organization”, “name”: “Clinicalstudies.in” },
“publisher”: {
“@type”: “Organization”,
“name”: “Clinicalstudies.in”,
“logo”: { “@type”: “ImageObject”, “url”: “https://www.clinicalstudies.in/logo.png” }
}
}

Clinical Trial Registration and Updates in ANZCTR SOP

Purpose

The purpose of this SOP is to define processes for clinical trial registration and updates in the Australia New Zealand Clinical Trials Registry (ANZCTR). This ensures transparency, ethical compliance, and alignment with Medsafe, HDEC, WHO, and International Committee of Medical Journal Editors (ICMJE) requirements for trial registration and result disclosure.

Scope

This SOP applies to all clinical trials conducted in New Zealand requiring ANZCTR registration. It covers initial registration, registry updates, posting of summary results, and management of registry-related communications. It applies to sponsors, investigators, CROs, regulatory affairs staff, and QA teams.

Responsibilities

• Sponsor: Ensures timely registration of all trials in ANZCTR before first participant enrollment, maintains updates, and discloses results.
• Principal Investigator (PI): Provides accurate trial data for registry submission and reviews registry entries for accuracy.
• Regulatory Affairs (RA): Manages registry submissions, updates, and correspondence with ANZCTR.
• CRO: Supports sponsor in registry management activities as per contractual agreement.
• Quality Assurance (QA): Audits registry records for compliance with SOP and regulatory requirements.

Accountability

The sponsor’s Head of Regulatory Affairs is accountable for compliance with ANZCTR registration requirements. The PI is accountable for ensuring site-level accuracy of trial information submitted to the registry.

Procedure

1. Initial Registration

1. Register the trial in ANZCTR prior to enrollment of the first participant.
2. Include all required information: protocol title, objectives, eligibility criteria, intervention details, and outcome measures.
3. Retain a copy of the registry confirmation in the TMF and ISF.

2. Updates to Registry Records

1. Update registry records within 15 working days of protocol amendments.
2. Maintain Registry Update Log (Annexure-1).

3. Results Disclosure

1. Submit summary results to ANZCTR within 12 months of trial completion.
2. Ensure consistency with final study report and regulatory submissions.

4. Ethics and Regulatory Coordination

1. Provide registry details in HDEC submissions.
2. Ensure Medsafe acknowledges trial registration for regulatory acceptance.

5. Auditing and Archiving

1. QA team audits registry entries annually for accuracy.
2. Archive all registry-related documents for minimum of 10 years.

Abbreviations

• ANZCTR: Australia New Zealand Clinical Trials Registry
• HDEC: Health and Disability Ethics Committees
• ICMJE: International Committee of Medical Journal Editors
• PI: Principal Investigator
• RA: Regulatory Affairs
• QA: Quality Assurance
• CRO: Contract Research Organization
• TMF: Trial Master File
• ISF: Investigator Site File

Documents

1. Registry Update Log (Annexure-1)
2. Registry Confirmation Record (Annexure-2)
3. Results Disclosure Log (Annexure-3)

References

• Australia New Zealand Clinical Trials Registry (ANZCTR)
• Medsafe — New Zealand Medicines and Medical Devices Safety Authority
• HDEC — Health and Disability Ethics Committees
• ICH E6(R2) Good Clinical Practice

Version: 1.0

Approval

Annexures

Annexure-1: Registry Update Log

Annexure-2: Registry Confirmation Record

Annexure-3: Results Disclosure Log

Revision History

For more SOPs visit: Pharma SOP.